Rescuing melanoma epitope-specific cytolytic T lymphocytes from activation-induced cell death, by SP600125, an inhibitor of JNK: Implications in cancer immunotherapy

Journal of Immunology

Volumn 173, Issue 10, 2004, Pages 6017-6024

  Mehrotra, Shikhar ^a   Chhabra, Arvind ^a   Chattopadhyay, Subhasis ^a   Dorsky, David I ^a   Chakraborty, Nitya G ^a   Mukherji, Bijay ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; GAMMA INTERFERON; MELAN A; STRESS ACTIVATED PROTEIN KINASE INHIBITOR;

ACTIVATION INDUCED CELL DEATH; ANTIGEN SPECIFICITY; APOPTOSIS; ARTICLE; CANCER IMMUNOTHERAPY; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; DRUG EFFECT; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; MELANOMA; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; WESTERN BLOTTING;

EID: 8444252435     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.10.6017     Document Type: Article

References (44)

1. Ashwell, J. D., R. E. Cunningham, P. D. Noguchi, and D. Hernandez. 1987. Cell growth cycle block of T cell hybridomas upon activation with antigen. J. Exp. Med. 165:173.
2. Shi, Y. F., B. Sahai, and D. R. Green. 1989. Cyclosporin A inhibits activation-induced cell death in T-cell hybridomas and thymocytes. Nature 339:625.
3. Budd, R. C. 2001. Activation-induced cell death. Curr. Opin. Immunol. 13:356.
4. Houghton, A. N. 1994. Cancer antigens: immune recognition of self and altered self. J. Exp. Med. 180:1.
5. Parmiani, G., C. Castelli, P. Dalerba, R. Mortarini, L. Rivoltini, F. M. Marincola, and A. Anichini. 2002. Cancer immunotherapy with peptide based vaccines: what have we achieved: where are we going? J. Natl. Cancer Inst. 94:805.
6. Mukherji, B., N. G. Chakraborty, S. Yamasaki, T. Okino, H. Yamase, J. R. Sporn, S. K. Kurtzman, M. T. Ergin, J. Ozols, and J. Meehan. 1995. Induction of antigen-specific cytolytic T cells in situ in human melanoma by immunization with synthetic peptide-pulsed autologous antigen presenting cells. Proc. Natl Acad. Sci. USA 92:8078.
7. Mehrotra, S., R. Stevens, R. Zengou, N. G. Chakraborty, L. H. Butterfield, J. S. Economou, D. I. Dorsky, and B. Mukherji. 2003. Regulation of melanoma epitope-specific cytolytic T lymphocyte response by immature and activated dendritic cells, in vitro. Cancer Res. 63:5607.
8. Coulie, P. G., V. Brichard, A. Van Pel, T. Wolfel, J. Schneider, C. Traversari, S. Mattei, E. De Plaen, C. Lurquin, J. P. Szikora, et al. 1994. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 180:35.
9. Kawakami, Y., S. Eliyahu, K. Sakaguchi, P. F. Robbins, L. Rivoltini, J. R. Yannelli, E. Appella, and S. A. Rosenberg. 1994. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J. Exp. Med. 180:347.
10. + T cell response to repetitive stimulation with antigen-presenting cells in vitro: implications in designing antigen-presenting cell-based tumor vaccines. J. Immunol. 162:5576.
11. Mukherji, B., A. Guha, N. G. Chakraborty, M. Sivanandham, A. L. Hashed, J. R. Sporn, and M. T. Ergin. 1989. Clonal analysis of cytotoxic and regulatory T cell responses against human melanoma. J. Exp. Med. 169:1961.
12. Lenardo, M. J. 1991. Interleukin-2 programs mouse, αβ T lymphocytes for apoptosis. Nature 353:858.
13. Waldmann, T. A., S. Dubois, and Y. Tagaya. 2001. Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for immunotherapy. Immunity 14:105.
14. Schluns, K. S., and L. Lefrancois. 2003. Cytokine control of memory T-cell development and survival. Nat. Rev. Immunol. 3:269.
15. + T cells in vivo by IL-15. Immunity 8:591.
16. Dong, C., R. J. Davis, and R. A. Flavell. 2002. MAP kinases in the immune response. Annu. Rev. Immunol. 20:55.
17. + T cells. Immunol. Rev. 192:131.
18. Green, D. R., and J. C. Reed. 1998. Mitochondria and apoptosis. Science 281:1309.
19. Perl, A., P. Gergely, Jr., G. Nagy, A. Koncz, and K. Banki. 2004. Mitochondrial hyperpolarization: a checkpoint of T-cell life, death and autoimmunity. Trends Immunol. 25:360.
20. 2+ and redox dependent production of nitric oxide. J. Immunol. 171:5188.
21. Banki, K., E. Hutter, N. J. Gonchoroff, and A. Perl. 1999. Elevation of mitochondrial transmembrane potential and reactive oxygen intermediate levels are early events and occur independently from activation of caspases in Fas signalling. J. Immunol. 162:1466.
22. Adams, J. A., and S. Cory. 1998. The Bcl-2 protein family: arbiters of cell survival. Science 281:1322.
23. Murali-Krishna, K., J. D. Altman, M. Suresh, D. J. Sourdive, A. J. Zajac, J. D. Miller, J. Slansky, and R. Ahmed. 1998. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8:177.
24. van Parjis, L., and A. K. Abbas. 1998. Homeostasis and self-tolerance: turning lymphocytes off. Science 280:243.
25. Dhein, J., H. Walczak, C. Baumler, K. Debatin, and P. Krammer. 1995. Autocrine T-cell suicide mediated by Apo-1 (Fas/CD95). Nature 373:438.
26. Zheng, L., G. Fisher, R. E. Miller, J. Peschon, D. H. Lynch, and M. J. Lenardo. 1995. Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 377:348.
27. Hildeman, D. A., Y. Zhu, T. C. Mitchell, J. Kappler, and P. Marrack. 2002. Molecular mechanisms of activated T cell death in vivo. Curr. Opin. Immunol. 14:354.
28. Jaattela, M., and J. Tschopp. 2003. Caspase-independent cell death in T lymphocytes. Nat. Immunol. 4:416.
29. Hildeman, D. A., T. Mitchell, T. K. Teague, P. Henson, B. J. Day, J. Kappler, and P. C. Marrack. 1999. Reactive oxygen species regulate activation-induced T cell apoptosis. Immunity 10:735.
30. + T cells during viral infection. J. Immunol. 170:4745.
31. + T cells after infection. Nat. Immunol. 3:619.
32. Michel, J., S. Pauly, J. Langstein, P. H. Krammer, and H. Schwarz. 1999. CD137-induced apoptosis is independent of CD95. Immunology 98:42.
33. Cooper, D., P. Bansal-Pakala, and M. Croft. 2002. 4-1BB (CD137) controls the clonal expansion and survival of CD8 T cells in vivo but does not contribute to the development of cytotoxicity. Eur. J. Immunol. 32:521.
34. Cannons, J. L., K. P. Hoeflich, J. R. Woodgett, and T. H. Watts. 1999. Role of the stress kinase pathway in signaling via the T cell costimulatory receptor 4-1BB. J. Immunol. 163:2990.
35. Manning, A. M., and R. J. Davis, 2003. Targeting JNK for therapeutic benefit: from junk to gold? Nat. Rev. Drug Discov. 2:554.
36. Zhu, L., X. Yu, Y. Akatsuka, J. A. Cooper, and C. Anasetti. 1999. Role of mitogen-activated protein kinases in activation-induced apoptosis of T cells. Immunology 97:26.
37. + T cells. Mol. Cell. Biol. 20:936.
38. Sabapathy, K., T. Kallunki, J. P. David, I. Fraef, M. Karn, and E. F. Wagner. 2001, c-Jun NH2-terminal kinase and JNK2 have similar and stage-dependent roles in regulating T cell apoptosis and proliferation. J. Exp. Med. 193:317.
39. + T cell activation. J. Exp. Med. 195:811.
40. + T cell-mediated antiviral immunity. J. Exp.. Med. 195:801.
41. Tournier, C., P. Hess, D. D. Yang, J. Xu, T. K. Turner, A, Nimnual, D. Bar-Sagi, S. N. Jones, R. A. Flavell, and R. J. Davis. 2000. Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science 288:870.
42. 2/M. Mol. Cell. Biol 19:8469.
43. Blagosklonny, M. V., P. Giannakakou, W. S. el-Deiry, D. G. Kingston, P. I. Higgs, L. Neckers, and T. Fojo. 1997. Raf-1/bcl-2 phosphorylation: a step from microtubule damage to cell death. Cancer Res. 57:130.
44. Opferman, J. T., A. Letai, C. Beard, M. D. Sorcinelli, C. C. Ong, and S. J. Korsmeyer. 2003. Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1. Nature 426:671.